Ovarian clear cell carcinoma Book Section
| Authors: | Manning-Geist, B.; Gordhandas, S.; Ramalingam, P.; Zivanovic, O. |
| Editors: | Frumovitz, M.; Leitao, M. M. Jr; Ramalingam, P. |
| Article/Chapter Title: | Ovarian clear cell carcinoma |
| Abstract: | In the United States, it is estimated that there will be 21,410 new diagnoses of ovarian cancer, and 13,770 deaths from ovarian cancer. Ovarian clear cell carcinoma represents 5% to 10% of ovarian cancers in the United States. Ovarian clear cell carcinoma is a rare ovarian malignancy; as a result, clinical trials are not powered to make conclusions for ovarian clear cell carcinoma despite known differences in response to treatment. Recommendations for surveillance and treatment of ovarian clear cell carcinoma are nonspecific and follow recommendations for the most common histology of high-grade serous ovarian cancer. In this chapter, we will highlight the known distinct features of ovarian clear cell carcinoma and treatment recommendations. © 2023 Elsevier Inc. All rights reserved. |
| Keywords: | chemotherapy; surgery; radiation therapy; epithelial ovarian cancer; ca125; ovarian clear cell carcinoma; endometriosis; arid1a |
| Book Title: | Diagnosis and Treatment of Rare Gynecologic Cancers |
| ISBN: | 978-0-323-82938-0 |
| Publisher: | Elsevier Inc. |
| Publication Place: | Amsterdam, Netherlands |
| Date Published: | 2023-01-01 |
| Start Page: | 55 |
| End Page: | 76 |
| Language: | English |
| DOI: | 10.1016/b978-0-323-82938-0.00004-5 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Book Chapter: 4, part of "Section A: Ovarian cancers" -- Export Date: 1 May 2023 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
-
291Zivanovic -
47Gordhandas
Related MSK Work